A solution towards a viable compensation mechanism for injury from COVID-19 vaccines in Malaysia: A qualitative study

2019年冠状病毒病(COVID-19) 机制(生物学) 2019-20冠状病毒爆发 补偿(心理学) 严重急性呼吸综合征冠状病毒2型(SARS-CoV-2) 病毒学 医学 重症监护医学 心理学 内科学 认识论 传染病(医学专业) 爆发 疾病 哲学 社会心理学
作者
Fahirah Syaliza Mokhtar,Akmalia Mohamad Ariff,Nazura Abdul Manap,Nurul Masirah Mustaffa
出处
期刊:Heliyon [Elsevier]
卷期号:10 (3): e25204-e25204 被引量:1
标识
DOI:10.1016/j.heliyon.2024.e25204
摘要

BackgroundIt has been established that the existing compensation mechanism is not the favoured platform for vaccine recipients with Adverse Effects Following Immunisation (AEFI). With the mass production of vaccines during the COVID-19 pandemic, intensified by the mandatory National COVID-19 Immunisation Programme in Malaysia, an alternative resolution mechanism for compensation is long overdue. This qualitative study aims to propose a viable alternative dispute resolution (ADR) mechanism for those who suffer AEFI from COVID-19 vaccination, particularly the economically disadvantaged, older people, and disabled individuals in Malaysia.MethodsThe researchers conducted an in-depth focus group discussion in September 2022 involving seven participants representing key stakeholders in vaccine compensations from governmental agencies, non-governmental organisations (NGOs), and private institutions who were experts in litigation and legislation, consumer protection, and medical practices in Malaysia. The study utilised ATLAS. TI 22 to conduct a thematic analysis.FindingsThe analysis yielded three themes: existing mechanisms and their challenges, the role of ADR, and the solution for a vaccine injury compensation mechanism. The participants shared their knowledge and experience regarding the existing vaccine compensation mechanisms in Malaysia, i.e. the common law of Tort and Consumer Protection Act 1999, and explained how each mechanism relates to specific challenges or arguments that provide the basis on which they are unable to accord fair compensation to the vaccine recipients. The participants debated the merits and disadvantages of the types of ADR for AEFI and unanimously proposed a specific healthcare centre for compensation (SHCC) as the most viable compensation mechanism for AEFI.ConclusionSHCC offers a new ADR to serve as a compensation mechanism for claimants affected by the COVID-19 vaccines while also contributing to achieving Sustainable Development Goal 16: peace, justice, and strong institutions.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
橙子快跑发布了新的文献求助10
1秒前
粗犷的秋凌完成签到 ,获得积分10
2秒前
SEAMUS发布了新的文献求助10
3秒前
余盼盼完成签到,获得积分10
3秒前
4秒前
4秒前
Ava应助谨慎笑蓝采纳,获得10
6秒前
srkeeper关注了科研通微信公众号
7秒前
7秒前
脑洞疼应助chen采纳,获得10
8秒前
8秒前
8秒前
8秒前
不配.应助科研通管家采纳,获得10
8秒前
英姑应助科研通管家采纳,获得10
8秒前
8秒前
不配.应助科研通管家采纳,获得10
9秒前
Flanker应助科研通管家采纳,获得10
9秒前
隐形曼青应助科研通管家采纳,获得10
9秒前
Rick发布了新的文献求助10
9秒前
桐桐应助科研通管家采纳,获得10
9秒前
buno应助科研通管家采纳,获得10
9秒前
不配.应助科研通管家采纳,获得10
9秒前
小蘑菇应助科研通管家采纳,获得10
9秒前
ccm应助科研通管家采纳,获得10
9秒前
科目三应助科研通管家采纳,获得10
9秒前
科研通AI2S应助科研通管家采纳,获得10
9秒前
打打应助科研通管家采纳,获得10
9秒前
搜集达人应助科研通管家采纳,获得10
10秒前
酷波er应助科研通管家采纳,获得10
10秒前
pluto应助科研通管家采纳,获得10
10秒前
小二郎应助科研通管家采纳,获得10
10秒前
buno应助科研通管家采纳,获得10
10秒前
10秒前
10秒前
10秒前
10秒前
constant完成签到,获得积分10
10秒前
打打应助阿牛奶采纳,获得10
11秒前
重要的问芙完成签到,获得积分10
11秒前
高分求助中
歯科矯正学 第7版(或第5版) 1004
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 700
Mesopotamian divination texts : conversing with the gods : sources from the first millennium BCE 500
The Heath Anthology of American Literature: Early Nineteenth Century 1800 - 1865 Vol. B 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
Machine Learning for Polymer Informatics 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3222817
求助须知:如何正确求助?哪些是违规求助? 2871641
关于积分的说明 8176254
捐赠科研通 2538573
什么是DOI,文献DOI怎么找? 1370638
科研通“疑难数据库(出版商)”最低求助积分说明 645828
邀请新用户注册赠送积分活动 619710